The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD) Meeting Abstract
| Authors: | Cora, N. S.; Sergio, B.; Ugo, D. G.; Giuseppe, P.; Simon, C.; Wassim, A.; Angel, A. A. J.; Gedske, D.; Karim, F.; Eliahu, G.; Axel, H.; Florence, J.; Ray, M.; Axel, S. M.; Maria, P. J.; Brieuc, S.; Srikala, S.; Tony, G.; Charles, J. R.; Howard, I. S. |
| Abstract Title: | The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD) |
| Meeting Title: | 19th National Congress of Medical Oncology |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2017 Oct 27-29 |
| Meeting Location: | Rome, Italy |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-10-01 |
| Start Page: | mdx423.019 |
| Language: | English |
| ACCESSION: | WOS:000414493900069 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx423.019 |
| Notes: | Meeting Abstract: B20 -- Appears on page vi23 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
